Kenvue Inc
KVUE23.010USD
+0.260+1.14%
Fechamento 04/25, 16:00（ET）Cotações atrasadas em 15 min
44.04BValor de mercado
42.75P/L TTM
Mais detalhes de Kenvue Inc Empresa
Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Informações da empresa
Código da empresaKVUE
Nome da EmpresaKenvue Inc
Data de listagemMay 04, 2023
Fundado em2022
CEOMr. Thibaut Mongon
Número de funcionários22000
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 04
Endereço1 Kenvue Way
CidadeSUMMIT
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal07901
Telefone19088741200
Sitehttps://www.kenvue.com
Código da empresaKVUE
Data de listagemMay 04, 2023
Fundado em2022
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Thibaut Mongon
Mr. Thibaut Mongon
Chief Executive Officer, Director
Chief Executive Officer, Director
216.47K
+8.04%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Mr. Paul Ruh
Mr. Paul Ruh
Chief Financial Officer
Chief Financial Officer
56.20K
+6.89%
Ms. Bing (Ellie) Xie
Ms. Bing (Ellie) Xie
Group President, Asia Pacific
Group President, Asia Pacific
47.60K
+8.84%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
31.36K
+9.72%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
28.44K
+52.59%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Thibaut Mongon
Mr. Thibaut Mongon
Chief Executive Officer, Director
Chief Executive Officer, Director
216.47K
+8.04%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Mr. Paul Ruh
Mr. Paul Ruh
Chief Financial Officer
Chief Financial Officer
56.20K
+6.89%
Ms. Bing (Ellie) Xie
Ms. Bing (Ellie) Xie
Group President, Asia Pacific
Group President, Asia Pacific
47.60K
+8.84%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Face and Body Care
2.94B
19.00%
Other Self Care
2.32B
15.00%
Cough, Cold and Allergy
2.16B
14.00%
Pain Care
2.01B
13.00%
Other Essential Health
1.70B
11.00%
Other
4.33B
28.00%
Por RegiãoUSD
Nome
Receita
Proporção
Northern America
7.58B
49.04%
Europe, Middle East, and Africa
3.56B
23.03%
Asia - Pacific
2.97B
19.24%
Latin America
1.34B
8.69%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Face and Body Care
2.94B
19.00%
Other Self Care
2.32B
15.00%
Cough, Cold and Allergy
2.16B
14.00%
Pain Care
2.01B
13.00%
Other Essential Health
1.70B
11.00%
Other
4.33B
28.00%
Acionista
Tempo de atualização: sex, 21 de fev
Tempo de atualização: sex, 21 de fev
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
T. Rowe Price Associates, Inc.
12.62%
The Vanguard Group, Inc.
11.35%
State Street Global Advisors (US)
6.28%
Fidelity Management & Research Company LLC
5.53%
MFS Investment Management
4.89%
Other
59.34%
Estatísticas dos acionistas
Acionista
Proporção
T. Rowe Price Associates, Inc.
12.62%
The Vanguard Group, Inc.
11.35%
State Street Global Advisors (US)
6.28%
Fidelity Management & Research Company LLC
5.53%
MFS Investment Management
4.89%
Other
59.34%
Tipo
Acionista
Proporção
Investment Advisor
47.13%
Investment Advisor/Hedge Fund
44.82%
Hedge Fund
3.00%
Research Firm
2.71%
Pension Fund
1.87%
Sovereign Wealth Fund
1.36%
Bank and Trust
1.18%
Family Office
0.19%
Family Office
0.19%
Participação acionária institucional
Tempo de atualização: dom, 19 de jan
Tempo de atualização: dom, 19 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
1954
1.96B
102.81%
-254.82M
2024Q4
1944
1.96B
102.60%
-253.31M
2024Q3
1828
1.91B
99.61%
-331.64M
2024Q2
1723
1.90B
99.19%
-79.08M
2024Q1
1598
1.90B
99.47%
-51.94M
2023Q4
1442
1.89B
98.66%
-22.82M
2023Q3
1206
1.90B
99.22%
-343.08M
2023Q2
232
1.95B
101.85%
+1.90B
2023Q1
1
--
0.00%
-14.23K
2022Q4
1
--
0.00%
-14.23K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
T. Rowe Price Associates, Inc.
242.05M
12.66%
+8.03M
+3.43%
Dec 31, 2024
The Vanguard Group, Inc.
217.71M
11.39%
+1.67M
+0.77%
Dec 31, 2024
State Street Global Advisors (US)
120.40M
6.3%
-6.81M
-5.36%
Dec 31, 2024
Fidelity Management & Research Company LLC
106.19M
5.56%
-9.01M
-7.82%
Dec 31, 2024
MFS Investment Management
93.86M
4.91%
+10.11M
+12.07%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
93.06M
4.87%
+2.22M
+2.44%
Dec 31, 2024
Wellington Management Company, LLP
68.36M
3.58%
-10.72M
-13.56%
Dec 31, 2024
Geode Capital Management, L.L.C.
46.07M
2.41%
+1.39M
+3.12%
Dec 31, 2024
Harris Associates L.P.
31.52M
1.65%
+58.77K
+0.19%
Dec 31, 2024
Managed Account Advisors LLC
25.86M
1.35%
-11.13M
-30.10%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
Renaissance IPO ETF
9.45%
VanEck Morningstar Wide Moat Value ETF
4.62%
Cullen Enhanced Equity Income ETF
3.98%
TBG Dividend Focus ETF
3.63%
TrueShares Low Volatility Equity Income ETF
3.14%
First Trust US Equity Opportunities ETF
3.04%
Invesco S&P 500 Equal Weight Consumer Staples ETF
2.94%
ProShares Ultra Consumer Staples
2.63%
Consumer Staples Select Sector SPDR Fund
2.62%
iShares US Consumer Staples ETF
2.26%
Ver Mais
Renaissance IPO ETF
Proporção9.45%
VanEck Morningstar Wide Moat Value ETF
Proporção4.62%
Cullen Enhanced Equity Income ETF
Proporção3.98%
TBG Dividend Focus ETF
Proporção3.63%
TrueShares Low Volatility Equity Income ETF
Proporção3.14%
First Trust US Equity Opportunities ETF
Proporção3.04%
Invesco S&P 500 Equal Weight Consumer Staples ETF
Proporção2.94%
ProShares Ultra Consumer Staples
Proporção2.63%
Consumer Staples Select Sector SPDR Fund
Proporção2.62%
iShares US Consumer Staples ETF
Proporção2.26%
Dividendo
Um total de
2.32B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jan 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
Feb 12, 2025
Feb 26, 2025
Feb 12, 2025
Oct 17, 2024
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 27, 2024
Nov 13, 2024
Jul 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 28, 2024
Aug 14, 2024
Apr 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
May 08, 2024
May 22, 2024
May 07, 2024
Jan 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
Feb 14, 2024
Feb 28, 2024
Feb 13, 2024
Oct 26, 2023
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 22, 2023
Nov 07, 2023
Jul 20, 2023
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023
Aug 28, 2023
Sep 07, 2023
Aug 25, 2023
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados